Short description
AIkido Pharma develops drugs and supplements, and offers a commercialization platform for protected technologies.
Description
The Company's platform consists of patented technology from leading universities and researchers and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, we are constantly seeking to grow our pipe to treat unmet medical needs in oncology.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Washington, District of Columbia, United States, North America
Founded on
January 1, 1967
Exited on
December 12, 2010
Went public on
December 12, 2010
Stock symbol
AIKI
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$1230 - 4560
Sign in for full access
Founders
Gilbert V. Levin, M. Karen Levin
Funding rounds count
1
Portfolio organisations count
Absolutely Noaccess, Nopepepe
Sign in for full access
Lead investments count
1